Robeco Institutional Asset Management B.V. Grows Stake in Corteva, Inc. $CTVA

Robeco Institutional Asset Management B.V. grew its stake in shares of Corteva, Inc. (NYSE:CTVA) by 125.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 891,366 shares of the company’s stock after purchasing an additional 496,647 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.13% of Corteva worth $60,283,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. CWA Asset Management Group LLC lifted its position in Corteva by 6.4% during the 3rd quarter. CWA Asset Management Group LLC now owns 18,385 shares of the company’s stock worth $1,243,000 after acquiring an additional 1,108 shares in the last quarter. City Holding Co. raised its stake in shares of Corteva by 25.3% during the third quarter. City Holding Co. now owns 22,323 shares of the company’s stock valued at $1,510,000 after purchasing an additional 4,503 shares during the period. TriaGen Wealth Management LLC acquired a new position in shares of Corteva during the third quarter worth $4,284,000. Commonwealth Equity Services LLC boosted its stake in shares of Corteva by 1.2% in the third quarter. Commonwealth Equity Services LLC now owns 144,775 shares of the company’s stock valued at $9,791,000 after purchasing an additional 1,676 shares during the period. Finally, Asset Management One Co. Ltd. grew its holdings in Corteva by 3.7% during the 3rd quarter. Asset Management One Co. Ltd. now owns 343,122 shares of the company’s stock valued at $23,205,000 after purchasing an additional 12,085 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Up 2.1%

Shares of NYSE CTVA opened at $69.25 on Wednesday. The stock’s 50 day moving average price is $65.73 and its two-hundred day moving average price is $68.85. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $77.41. The stock has a market capitalization of $46.80 billion, a P/E ratio of 29.60, a PEG ratio of 1.39 and a beta of 0.74. The company has a quick ratio of 1.07, a current ratio of 1.58 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, November 4th. The company reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.49) by $0.26. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The company had revenue of $2.62 billion during the quarter, compared to analyst estimates of $2.47 billion. The business’s revenue was up 6.5% on a year-over-year basis. During the same quarter last year, the firm earned ($0.49) EPS. On average, analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Monday, December 1st were paid a dividend of $0.18 per share. The ex-dividend date was Monday, December 1st. This represents a $0.72 annualized dividend and a yield of 1.0%. Corteva’s payout ratio is presently 30.77%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on CTVA shares. Mizuho cut their price objective on shares of Corteva from $85.00 to $78.00 and set an “outperform” rating on the stock in a report on Wednesday, October 8th. Wall Street Zen cut Corteva from a “buy” rating to a “hold” rating in a research note on Saturday. Wolfe Research increased their price target on Corteva from $79.00 to $80.00 and gave the company an “outperform” rating in a report on Thursday, November 6th. KeyCorp restated a “sector weight” rating on shares of Corteva in a report on Friday, October 3rd. Finally, Deutsche Bank Aktiengesellschaft cut their target price on Corteva from $90.00 to $85.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and an average target price of $78.21.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.